(Q38063427)

28 August 2017

1 reference

title

Atypical serological profiles in hepatitis B virus infection (English)

1 reference

28 August 2017

1 reference

Robério A A Pondé

1

1 reference

28 August 2017

publication date

29 November 2012

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

28 August 2017

published in

1 reference

28 August 2017

volume

32

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

461-476

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-012-1781-9

28 August 2017

exact match

0 references

cites work

Immunology of hepatitis B infection

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Diagnosis of hepatitis B virus infection through serological and virological markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Pathogenesis of hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Genetic variation in HBV infection: genotypes and mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Mutations affecting the replication capacity of the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Immune tolerance split between hepatitis B virus precore and core proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Chronic hepatitis B virus infection in an anti-HBc-nonreactive blood donor: variant virus or defective immune response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Blood donors infected with the hepatitis B virus but persistently lacking antibodies to the hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Absence or delayed appearance of hepatitis B core antibody in chronic hepatitis B surface antigen carrier children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Transformation of hepatitis B serologic markers in babies born to hepatitis B surface antigen positive mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

HBsAG positive reactivity in man not due to hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Characterization of HBV2-like infections in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Hepatitis B virus C gene heterogeneity in a familial cluster of anti-HBc negative chronic carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

The serology of chronic hepatitis B infection revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Demonstration of a firm association between hepatitis B surface antigen proteins bearing polymerized human albumin binding sites and core-specific determinants in serum hepatitis B viral particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Conserved core protein sequences in hepatitis B virus infected patients without anti-HBc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Viral determinants and host immune responses in the pathogenesis of HBV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Occult hepatitis B virus in liver tissue of individuals without hepatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Long-term histologic and virologic outcomes of acute self-limited hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Detecting hepatitis B surface antigen mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100 IU/l seroprotection levels unreliable

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

The clinical significance of surface antigen variants of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Mutations of some critical amino acid residues in the hepatitis B virus surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

The hepatitis B virus and common mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Current topics in hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Detection of HBsAg mutants in a population with a low prevalence of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Vaccine-induced escape mutant of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

A novel hepatitis B virus variant in the sera of immunized children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Selection of hepatitis B surface "escape" mutants during passive immune prophylaxis following liver transplantation: potential impact of genetic changes on polymerase protein function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Intra-familial evidence of horizontal transmission of hepatitis B virus surface antigen mutant G145R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Infection with hepatitis B virus carrying novel pre-S/S gene mutations in female siblings vaccinated at birth: two case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Hepatitis B virus DNA in unusual serological profiles of hepatitis B surface antigen-positive sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

A novel deletion mutant of hepatitis B virus surface antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Molecular, immunological and clinical properties of mutated hepatitis B viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Molecular virology of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

The concept of hepatitis B virus mutant escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Classifying hepatitis B virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Genetic variability in hepatitis B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Hepatitis B virus: significance of genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

The core promoter of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Precore and core promoter mutations, hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-b, non-c chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Diagnosis of hepatitis B infections and monitoring of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Immune effectors required for hepatitis B virus clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or After HBs vaccination: Stimulation of thein vitroantibody response by interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Immunogenetics of the response to HBsAg vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Hepatitis B core IgM antibody (anti-HBcIgM) among hepatitis B surface antigen (HBsAg) negative blood donors in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Distribution Characteristics of Hepatitis B Serological Markers in Hospitalized Children and Adolescents in Zhejiang, China between 2006 and 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating Anti-HBs antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Heterogeneity of hepatitis B virus (HBV) core gene in a patient with HBV-associated cirrhosis and serum negativity for anti-HBc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Nucleotide sequence of the precore/core gene and X gene of hepatitis B virus DNA in asymptomatic hepatitis B virus carriers who are negative for serum hepatitis B core antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Clinical and serological variation between patients infected with different Hepatitis B virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Reappearance of hepatitis B surface antigen in immunocompromised individuals: reinfection or reactivation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

The clinical implications of hepatitis B virus genotype: Recent advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

What can be revealed by extending the sensitivity of HBsAg detection to below the present limit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Presence of low levels of anti-HBs antibody in so-called 'anti-HBc alone' subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Absence of anti-hepatitis B surface antibody after vaccination does not necessarily mean absence of immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1781-9

Naturally occurring variants of hepatitis B virus

21 January 2018

1 reference

12 December 2020

Hepatitis B virus reinfection after liver transplantation: related risk factors and perspective.

1 reference

12 December 2020

Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer.

1 reference

12 December 2020

Variants of two major T cell epitopes within the hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals

1 reference

12 December 2020

Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen

1 reference

12 December 2020

Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen

1 reference

12 December 2020

Coincident hepatitis B surface antigen and antibodies of different subtypes in human serum

1 reference

12 December 2020

Excess HBcAg in HBc antibody-negative chronic hepatitis B virus carriers

1 reference

12 December 2020

Do T cells "see" the hepatitis B core and e antigens differently?

1 reference

12 December 2020

Prevention of hepatitis B virus reinfection after orthotopic liver transplantation

1 reference

12 December 2020

Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg

1 reference

12 December 2020

Immunoassay detection of hepatitis B surface antigen mutants

1 reference

12 December 2020

Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays.

1 reference

12 December 2020

Pathology of livers infected with "silent" hepatitis B virus mutant

1 reference

12 December 2020

Clinical course and consequences of hepatitis B infection

1 reference

12 December 2020

Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients

1 reference

12 December 2020

Occult hepatitis B virus infection

1 reference

12 December 2020

Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection

1 reference

12 December 2020

[Significance of hepatitis B core antibody as the only marker of hepatitis B infection]

1 reference

12 December 2020

Quantitation of hepatitis B virus (HBV) core antigen in serum in the presence of antibodies to HBV core antigen: comparison with assays of serum HBV DNA, DNA polymerase, and HBV e antigen.

1 reference

12 December 2020

High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology

1 reference

12 December 2020

Changing scene in hepatitis B serology interpretation

1 reference

12 December 2020

Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro

1 reference

12 December 2020

The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence

1 reference

12 December 2020

The small envelope protein is required for secretion of a naturally occurring hepatitis B virus mutant with pre-S1 deleted.

1 reference

12 December 2020

CccDNA persistence during natural evolution of chronic VHB infection

1 reference

12 December 2020

Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen

1 reference

12 December 2020

Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs

1 reference

12 December 2020

Detection of HBsAg mutants

1 reference

12 December 2020

The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.

1 reference

12 December 2020

10.1007/S10096-012-1781-9

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1014675183

0 references

1 reference